Application of lixisenatide in the preparation of antitumor drugs
An anti-tumor drug, lixisenatide technology, applied in the field of tumor treatment, can solve the problem of no lixisenatide, no immune activation or anti-tumor immune activation data or results, etc., to inhibit tumor growth, delay metastasis and recurrence , the effect of prolonging survival
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0023] Example 1 Detection of the immune activation function of polypeptide drugs on peripheral blood mononuclear cells
[0024] 1. Experimental method
[0025] 1. Determination of screening objects
[0026] We used the DrugBank database to search for peptide drugs, excluding FDA-approved peptides for the treatment of infectious diseases, treatment of blood system diseases, tumor therapy and immune regulation, and the functions of the approved peptides are not related to tumor therapy and immune regulation Relationship. The functions focus on the treatment of hormone disorders, treatment of sexual dysfunction, treatment of diabetes, treatment of gastrointestinal diseases, treatment of genetic diseases, treatment of cardiovascular diseases, treatment of bone diseases, treatment of nervous system diseases, treatment of respiratory disorders, treatment of eye disorders, treatment of absorption bad disease. This includes peptide drugs for diabetes treatment. In addition, the s...
Embodiment 2
[0036] Example 2 Observation of the therapeutic effect of lixisenatide on a normal mouse melanoma model
[0037] 1. Experimental method
[0038] We used normal healthy mice C57BL / 6, mice with sound immunity and normal blood sugar, mainly wanting to bear tumors (melanoma model) on mice with sound immunity and normal blood sugar, and then observe the therapeutic effect and immune activation. Since it is tumor-bearing in mice with sound immunity and normal blood sugar, if lixisenatide is effective, then such a function does not depend on its existing function-lowering blood sugar.
[0039] A 6-8 week old C57BL / 6 mouse was selected to establish a subcutaneous melanoma model in the right axilla. Each mouse was inoculated with 5×10 6 A B16 / F10 melanoma cell, the tumor size was measured to about 200mm after about 6 days 3 , the mice were randomly divided into 2 groups, 12 in each group, respectively: PBS control group (100 μl PBS) and lixisenatide subcutaneous injection treatment ...
Embodiment 3
[0046] Example 3 Observation of the therapeutic effect of lixisenatide subcutaneous injection on a normal mouse breast cancer model
[0047] 1. Experimental method
[0048] We used normal healthy BALB / c female mice with healthy immune system and normal blood sugar. We mainly want to carry tumors (breast cancer model) on mice with healthy immune system and normal blood sugar, and then observe the therapeutic effect and immune activation . Since it is tumor-bearing in mice with sound immunity and normal blood sugar, if lixisenatide is effective, then such a function does not depend on its existing function-lowering blood sugar.
[0049] BALB / c female mice aged 6-8 weeks were selected to establish a subcutaneous breast cancer model in the right axillary fat pad. Each mouse was inoculated with 5×10 6 4T1 breast cancer cells in mice, the tumor size was measured to about 200mm after about 8 days 3 , the mice were randomly divided into 2 groups, 12 in each group, respectively: PB...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com